Odonate Therapeutics, Inc.
Odonate Therapeutics, Inc. (ODTC) Stock Overview
Explore Odonate Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
8B
P/E Ratio
3227.30
EPS (TTM)
$20580.00
ROE
0.07%
ODTC Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Odonate Therapeutics, Inc. (ODTC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 3227.30 and a market capitalization of 8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.